Bangladesh, April 7 -- Within the intricate tapestry of modern healthcare, the pricing of pharmaceuticals stands as a focal point for debate and scrutiny. Here, the imperatives of innovation, profit, and the ethical mandate of universal access to vital medications intersect, weaving a complex and often contentious narrative. As we stand on the precipice of a pivotal juncture in the pharmaceutical industry, it becomes imperative to unravel the multifaceted dynamics that underpin drug pricing and their far-reaching implications for global health equity.

At the core of this discourse lies the enduring legacy of George Merck, whose advocacy for the belief that medicine should prioritize serving people over profit margins resonates deeply. Ho...